Dinaciclib T1912
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Dinaciclib is a new-type and effective CDK inhibitor for CDK2/5/1/9 (IC50: 1 nM/1 nM/3 nM/4 nM) with potential antineoplastic activity.
CAS nr:
779353-01-4
Purity:
98%
Molecular Weight:
396,49
SMILES:
CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO
Formula:
C21H28N6O2
Pathway:
Cell Cycle/Checkpoint,Apoptosis
Target:
CDK,Apoptosis
